These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 1960118)

  • 1. Characterization of FCE 22101-resistant Enterobacteriaceae and the effect of FCE 22101 upon the activity of anti-pseudomonal beta-lactams for Pseudomonas aeruginosa.
    Piddock LJ; Traynor EA
    J Antimicrob Chemother; 1991 Sep; 28(3):369-75. PubMed ID: 1960118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. beta-Lactamase expression and outer membrane protein changes in cefpirome-resistant and ceftazidime-resistant gram-negative bacteria.
    Piddock LJ; Traynor EA
    J Antimicrob Chemother; 1991 Aug; 28(2):209-19. PubMed ID: 1778852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the mechanisms of decreased susceptibility of aztreonam-resistant and ceftazidime-resistant Enterobacteriaceae.
    Piddock LJ; Traynor EA; Wise R
    J Antimicrob Chemother; 1990 Dec; 26(6):749-62. PubMed ID: 2081717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selection and characterization of cefepime-resistant gram-negative bacteria.
    Piddock LJ; Griggs DJ
    J Antimicrob Chemother; 1991 Nov; 28(5):669-76. PubMed ID: 1778870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-vitro activity of FCE 22101 and other beta-lactam antibiotics against Enterobacteriaceae resistant to third generation cephalosporins.
    Jarlier V; Nicolas MH; Philippon A; Giroir AM; Grosset J
    J Antimicrob Chemother; 1989 Aug; 24(2):165-72. PubMed ID: 2676939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Fluoroquinolone and aminoglycoside resistance in chromosomal cephalosporinase-overproducing gram-negative bacilli strains with inducible beta-lactamase].
    López-Yeste M; Xercavins M; Lite J; Cuchí E; Garau J
    Enferm Infecc Microbiol Clin; 1996 Apr; 14(4):211-4. PubMed ID: 9044634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors that influence the evolution of beta-lactam resistance in beta-lactamase-inducible strains of Enterobacter cloacae and Pseudomonas aeruginosa.
    Aronoff SC; Shlaes DM
    J Infect Dis; 1987 May; 155(5):936-41. PubMed ID: 3104483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance development profiling of piperacillin in combination with the novel {beta}-lactamase inhibitor BLI-489.
    Ruzin A; Petersen PJ; Jones CH
    J Antimicrob Chemother; 2010 Feb; 65(2):252-7. PubMed ID: 20008048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-vitro activity of FCE 22101 and synergy studies with other antimicrobial agents.
    Chin NX; Neu HC
    J Antimicrob Chemother; 1989 Mar; 23 Suppl C():95-101. PubMed ID: 2786520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions of FCE 22101 with class I beta-lactamases.
    Yang Y; Livermore DM
    J Antimicrob Chemother; 1989 Mar; 23 Suppl C():85-94. PubMed ID: 2786519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [In vitro study of antibacterial activity of cefepime (Axepim) against gram negative bacteria: comparison with cephalosporins and other beta-lactams].
    Vachée A; Devalckenaere A; Husson MO; Izard D
    Pathol Biol (Paris); 1996 Feb; 44(2):132-7. PubMed ID: 8761598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inducible type I beta-lactamases of gram-negative bacteria and resistance to beta-lactam antibiotics.
    Curtis NA; Eisenstadt RL; Rudd C; White AJ
    J Antimicrob Chemother; 1986 Jan; 17(1):51-61. PubMed ID: 3485092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of the beta-lactamases of a strain of Pseudomonas aeruginosa, Morganella morganii and Enterobacter cloacae.
    Farmer TH; Reading C
    J Antimicrob Chemother; 1987 Mar; 19(3):401-4. PubMed ID: 3106306
    [No Abstract]   [Full Text] [Related]  

  • 14. Phenotypic characterization of quinolone-resistant mutants of Enterobacteriaceae selected from wild type, gyrA type and multiply-resistant (marA) type strains.
    Piddock LJ; Hall MC; Walters RN
    J Antimicrob Chemother; 1991 Aug; 28(2):185-98. PubMed ID: 1663926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selectivity of ertapenem for Pseudomonas aeruginosa mutants cross-resistant to other carbapenems.
    Livermore DM; Mushtaq S; Warner M
    J Antimicrob Chemother; 2005 Mar; 55(3):306-11. PubMed ID: 15705643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. WCK 4234, a novel diazabicyclooctane potentiating carbapenems against Enterobacteriaceae, Pseudomonas and Acinetobacter with class A, C and D β-lactamases.
    Mushtaq S; Vickers A; Woodford N; Livermore DM
    J Antimicrob Chemother; 2017 Jun; 72(6):1688-1695. PubMed ID: 28333319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of cefpirome against beta-lactamase-inducible and stably derepressed Enterobacteriaceae.
    Binfiglio G; Stefani S; Nicoletti G
    Chemotherapy; 1994; 40(5):311-6. PubMed ID: 7956454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibacterial activity of FCE 22101 against relatively resistant blood culture isolates.
    Qadri SM; Ueno Y; Ellis ME
    Chemotherapy; 1991; 37(1):15-22. PubMed ID: 2013238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ceftazidime-avibactam activity when tested against ceftazidime-nonsusceptible Citrobacter spp., Enterobacter spp., Serratia marcescens, and Pseudomonas aeruginosa from Unites States medical centers (2011-2014).
    Sader HS; Castanheira M; Farrell DJ; Flamm RK; Jones RN
    Diagn Microbiol Infect Dis; 2015 Dec; 83(4):389-94. PubMed ID: 26162518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic therapy for inducible AmpC β-lactamase-producing Gram-negative bacilli: what are the alternatives to carbapenems, quinolones and aminoglycosides?
    Harris PN; Ferguson JK
    Int J Antimicrob Agents; 2012 Oct; 40(4):297-305. PubMed ID: 22824371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.